Product Information

PIOGLITAZONE HCL 15 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0647 per EA under NDC 65862051290. Its NADAC has been published 315 times since Aug 12, 2020.

FDA first approved this application on Feb 13, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PIOGLITAZONE HCL 15 MG TABLET

pioglitazone hydrochloride
$0.0647per EA

Strength

15 mg/1

NDC

65862051290

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PIOGLITAZONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA200268

FDA Approved

2/13/2013

TE Code

AB

On Market Since

2/13/2013

Pharmacological Classes

Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE HCL 15 MG TABLET has been published 315 times since Aug 12, 2020, and over the history we have for it it has declined 42.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0647 per EA
All-time high$0.1148 (Apr 14, 2021)
All-time low$0.0587 (Nov 20, 2024)
52-week high$0.0727
52-week low$0.0647
Median price$0.0836
Average price$0.0859
Largest weekly change-25.8% (Nov 20, 2024)
Weeks tracked315
Tracking sinceAug 12, 2020

Price History

1W

-2.2%

1M

-2.2%

3M

-7.7%

6M

-5.6%

1Y

-11.0%

3Y

-23.4%

5Y

-42.1%

All

-42.0%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE HCL 15 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 15 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0647 per EA (NDC 65862051290), effective Aug 19, 2026.

How has the price of PIOGLITAZONE HCL 15 MG TABLET changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE HCL 15 MG TABLET has declined 42.0%. It has been tracked across 315 weekly CMS publications since Aug 12, 2020.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 15 MG TABLET?

Since Aug 12, 2020, the NADAC for PIOGLITAZONE HCL 15 MG TABLET has ranged from a low of $0.0587 (Nov 20, 2024) to a high of $0.1148 (Apr 14, 2021), with a median of $0.0836 per EA.

Are there cheaper alternatives to PIOGLITAZONE HCL 15 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PIOGLITAZONE HCL 15 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PIOGLITAZONE HCL 15 MG TABLET?

PIOGLITAZONE HCL 15 MG TABLET (NDC 65862051290) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.